Researchers looking at new way to treat chronic kidney disease and heart failure

Researchers at St. Michael's Hospital are using adult bone marrow stem cells as they investigate a completely new way of treating chronic kidney disease and heart failure in rats. Credit: St. Michael's Hospital

Researchers at St. Michael's Hospital are using adult bone marrow stem cells as they investigate a completely new way of treating chronic kidney disease and heart failure in rats.

Dr. Darren Yuen and Dr. Richard Gilbert were the first to show, in 2010, that enriched improved heart and kidney function in rats with both diseases.

But they and other scientists wondered about the potential side effects of returning those cells to the body, such as forming tumours.

In a paper published online today in the journal Stem Cells, Drs. Yuen and Gilbert said they have since found that enriched bone marrow stem cells secrete hormones in the petri dish that, if injected into rats, has the same positive impact as the stem cells.

"We've shown that we can use these hormones, collected in the dish, to replicate the beneficial effects of the stem cells in treating animals with and ," said Dr. Yuen, a nephrologist. "In our view, this is a significant advance for stem cell therapies because it gets around having to inject stem cells."

Dr. Yuen said they do not yet know what kind of hormone the cells are secreting. Identifying the hormone would be the first step toward the goal of developing a synthetic drug.

Chronic kidney disease is much more prevalent than was once believed, with recent estimates suggesting that up to 5 per cent of the Canadian population may be affected. The number of people with CKD and end-stage renal failure is expected to rise as the population ages and more people develop Type 2 diabetes. People with often develop heart disease, and many of them die from heart failure rather than kidney failure.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Lost protein could prevent hardening of the arteries

24 minutes ago

(Medical Xpress)—Researchers have found that when the protein matrix metalloproteinase-14 (MMP-14) is reduced or lost, white blood cells, known as macrophages, become good and could prevent hardening of ...

A better way to track emerging cell therapies using MRIs

Sep 19, 2014

Cellular therapeutics – using intact cells to treat and cure disease – is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination ...

User comments